Brexit Effects On Medtech: View From Switzerland
While medtech trading economies and major exporting firms agonize over the effects that Brexit will have on their own future prospects, Switzerland, small in geographic terms but a major player in medtech and the global health care products industries generally, has been among the first to quantify its concerns.
You may also be interested in...
A few short weeks after the UK public voted in favor of leaving the EU – and several high-profile political casualties later – the issue is not yet of the Brexit dust settling, but of nervous preparations for when it will. Economic commentators, weighed down by news overkill, say that the true indications of what lies ahead are at least another month away: bad news indeed for those who find the short-term ride plenty bumpy enough.
BVMed says the EU and the UK should set up a system of mutual recognition of medical device regulation to kick in when the UK’s EU exit transition period ends on 31 December.
Corin has transformed from a niche UK hip resurfacing company into an innovative global player in orthopedics with a portfolio that includes robotics. UK branch managing director Paul Gibbons explained the group’s approach to business during COVID-19 and its culture of innovation.